Cumberland Pharmaceuticals Inc.'s (CPIX) supplemental New Drug Application seeking approval for a new simplified dosing regimen for Acetadote has received FDA approval and shares are up over 100% at $2.47 in premarket trading Tuesday.
Acetadote is used in hospital emergency departments to prevent or lessen the risk of liver damage following an acetaminophen overdose, which is often caused by overuse of over-the-counter pain relief and fever-reducing products.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com